Skip to main content

Table 1 Numbers of cases of monotherapy with DPP-4 inhibitors

From: Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus

Generic name

Trade name

Dose (daily)

Number of cases of monotherapy

Sitagliptin

Jauvia®, Glactive®

50 mg

879

Vildagliptin

Equa®

100 mg

253

Teneligliptin

Tenelia®

20 mg

260

Alogliptin

Nesina®

25 mg

237

Linagliptin

Trasenta®

5 mg

180

  1. DPP-4 dipeptidyl-peptidase 4